State Street SPDR S&P Biotech ETF XBI
ASignal view: Not yet rated
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Fund facts
Category
Health
Expense ratio
0.35%
AUM
$10.36B
Sector breakdown
Asset allocation
Signal overlay
ASignal covers 10 of 10 top holdings. Weighted across covered holdings:
BULLISH 20% · NEUTRAL 80% · BEARISH 0%
Top holdings
| Symbol | Name | Weight | ASignal |
|---|---|---|---|
| TWST | Twist Bioscience Corp | 2.2% | Neutral |
| MRNA | Moderna Inc | 2.0% | Neutral |
| NTRA | Natera Inc | 1.8% | Bullish |
| IOVA | Iovance Biotherapeutics Inc | 1.6% | Neutral |
| AMGN | Amgen Inc | 1.5% | Neutral |
| BIIB | Biogen Inc | 1.5% | Neutral |
| UTHR | United Therapeutics Corp | 1.5% | Neutral |
| ABBV | AbbVie Inc | 1.5% | Neutral |
| HALO | Halozyme Therapeutics Inc | 1.5% | Bullish |
| SYRE | Spyre Therapeutics Inc | 1.5% | Neutral |